• Headaches & Migraines

    We specialize in the treatment and management of Headache and Migraine disorders.

    read more
  • Parkinson’s Disease & Movement Disorders

    We are specialists in Parkinson’s Disease and other movement disorders from over 30+ years experience.

    read more
  • Epilepsy & Seizure Disorders

    Our doctors use the latest technology to help our patients live a calm, seizure free lifestyle.

    read more
  • Neuromuscular

    Don’t live in pain. Our neurologists are certified in the diagnosis and treatment of neuromuscular diseases.

    read more
  • Dizziness & Balance

    Dizziness can impair your everyday activities. Let us help you sort it all out.

    read more

Dr. Greenberg speaks about breakthroughs in Alzheimer’s Research

It steals your memories, your identity and your independence. More than 5.4 million Americans have Alzheimer’s disease. …

  • By Tasmin Mahfuz
  • © Ebru News
  • Mon Oct 28th 2013
  • Link to the complete article: CLICK HERE

Japanese researchers are getting a better picture of people with Alzheimer’s disease.

They’ve developed a nuclear scan to take images of proteins that accumulate in patients’ brains.

Scientists say these pictures will help doctors detect the disease in early stages.

Neurologist Dr. Jeffrey Greenberg of St. Peters University Hospital: “I consider it a very positive step. I think it’s an early step in imaging tau and tau pathology.”

Researchers believe two kinds of proteins build up abnormally in the patients’ brains – amyloid-beta and tau.

CT scans and MRIs can provide pictures of amyloid-beta but no one had developed technology to capture images of the protein called tau, until now.

Neurologist Dr. Jeffrey Greenberg of St. Peters University Hospital: “The tau protein in Alzheimer’s disease becomes defective, forms tangles called neurotic and is a marker of neurotic death or injury.”

Researchers developed a drug that combines exclusively with tau.

The drug which emits very low levels of radiation is injected into a patient’s brain.

Next in the scan, it lights up areas of the brain where the protein exists.

Neurologist Dr. Jeffrey Greenberg of St. Peters University Hospital: “The idea would be to identify the people a risk early on and see how we can interfere at that point.”

Researchers say being able to detect these proteins early will give patients a leg up on monitoring the disease.


Hospital Affiliation



Princeton and Rutgers Neurology is not affiliated with Rutgers University